+ Watch VAR
on My Watchlist
The Company designs, manufactures, sells and services advanced equipment and software products for treating cancer with radiation.
I think the recent pull-back provides a good entry-point for VAR. Their revenue and EPS are as solid as ever and rumor is that their managment may be expecting increased demand. Varian has been an outperformer for years and I see no reason this trend will stop anytime soon.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions